Pulmonary arterial hypertension in connective tissue diseases

Paul M. Hassoun, Britta Maurer, Oliver Distler

Research output: Contribution to journalReview articlepeer-review


Pulmonary arterial hypertension (PAH) is a common complication of connective tissue diseases (CTD) and a leading cause of death in this population. Despite significant advances in therapy for PAH, particularly for idiopathic PAH (IPAH), the response to treatment in patients with CTD associated with PAH, mainly in sclerodermaassociated PAH (SSc-PAH), has been quite disappointing. This chapter reviews the epidemiology, clinical manifestations, pathophysiology and currently available therapies for CTDassociated PAH with a particular focus on SSc-PAH, animal models of disease, and newly identified potential targets for therapy for this devastating syndrome.

Original languageEnglish (US)
Pages (from-to)42-57
Number of pages16
JournalEuropean Respiratory Monograph
StatePublished - 2012


  • Connective tissue disease
  • Pulmonary arterial hypertension
  • Systemic sclerosis
  • Therapy

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Pulmonary arterial hypertension in connective tissue diseases'. Together they form a unique fingerprint.

Cite this